These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24652271)

  • 1. Unilateral phrenic nerve palsy: a rare manifestation of vincristine neurotoxicity: authors' reply.
    Dhingra D; Sethi GR; Mantan M
    Indian J Pediatr; 2014 Dec; 81(12):1430. PubMed ID: 24652271
    [No Abstract]   [Full Text] [Related]  

  • 2. Unilateral phrenic nerve palsy: a rare manifestation of vincristine neurotoxicity.
    Dhingra D; Sethi GR; Mantan M
    Indian J Pediatr; 2014 Sep; 81(9):957-8. PubMed ID: 23801349
    [No Abstract]   [Full Text] [Related]  

  • 3. Unilateral phrenic nerve plasy: a rare manifestation of vincristine neurotoxicity: correspondence.
    Moriya K; Kakisaka Y; Onuma M; Sasahara Y; Kure S
    Indian J Pediatr; 2014 Dec; 81(12):1429. PubMed ID: 24652272
    [No Abstract]   [Full Text] [Related]  

  • 4. Phrenic nerve paralysis due to vincristine.
    Gilliland P; Holguin M
    Leuk Lymphoma; 2007 Dec; 48(12):2452-3. PubMed ID: 18067023
    [No Abstract]   [Full Text] [Related]  

  • 5. Vincristine-induced peripheral neuropathy: A mini-review.
    Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
    Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe vincristine neurotoxicity with concomitant use of itraconazole.
    Ariffin H; Omar KZ; Ang EL; Shekhar K
    J Paediatr Child Health; 2003 Nov; 39(8):638-9. PubMed ID: 14629538
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic factors influencing the development of vincristine-induced neurotoxicity.
    Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Cavaletti G
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):215-226. PubMed ID: 33283553
    [No Abstract]   [Full Text] [Related]  

  • 8. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
    Jain S; Kapoor G
    Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with vincristine--associated neurotoxicity.
    Othieno-Abinya NA; Nyabola LO
    East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.
    Boyette-Davis JA; Cata JP; Driver LC; Novy DM; Bruel BM; Mooring DL; Wendelschafer-Crabb G; Kennedy WR; Dougherty PM
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):619-26. PubMed ID: 23228992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma.
    Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S
    Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Mantadakis E; Amoiridis G; Kondi A; Kalmanti M
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):130. PubMed ID: 17279013
    [No Abstract]   [Full Text] [Related]  

  • 14. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
    Baker SK; Lipson DM
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
    Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
    Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
    [No Abstract]   [Full Text] [Related]  

  • 16. Appropriateness of maximum-dose guidelines for vincristine.
    McCune JS; Lindley C
    Am J Health Syst Pharm; 1997 Aug; 54(15):1755-8. PubMed ID: 9262750
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-threatening hyponatraemia and neurotoxicity during chemotherapy for Burkitt's lymphoma.
    Osier FH; Berkley JA; Newton CR
    Trop Doct; 2006 Jul; 36(3):177-8. PubMed ID: 16884631
    [No Abstract]   [Full Text] [Related]  

  • 18. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS; Riggs JE
    Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing the incidence of paclitaxel-induced peripheral neuropathy.
    Argyriou AA
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):522-3. PubMed ID: 19674075
    [No Abstract]   [Full Text] [Related]  

  • 20. Vincristine: Can its therapeutic index be enhanced?
    Moore A; Pinkerton R
    Pediatr Blood Cancer; 2009 Dec; 53(7):1180-7. PubMed ID: 19588521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.